A Study of HB0025 Injection in Patients With Advanced Renal Cancer

NCT06222125 · clinicaltrials.gov ↗
PHASE2
Phase
UNKNOWN
Status
100
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Huabo Biopharm Co., Ltd.